Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Kimberlee A Musser

Biographic Data

ID9993936
NAMEKimberlee A Musser
GIVEN NAMESKimberlee A
FAMILY NAMEMusser
SIGNATUREMUSSER K A
AFFILIATIONSNew York State Department of Health
ORCID0000-0003-1922-5405
VERIFIEDYes
TOTAL WORKS2
TOTAL CITATIONS0
AUTHOR COUNT2
EDITOR COUNT0
FIRST PUBLICATION YEAR2023
LATEST PUBLICATION YEAR2026
H-INDEX0
  • Investigation of invasive Neisseria meningitidis serogroup Y ST1466 case increases in New York State

    Open Access•Krithivasan Sankaranarayanan, Andrew Peifer et al.•ARTICLE•Frontiers in Public Health•2026

    Bacterial meningitis and septicemia caused by Neisseria meningitidis is a serious infection that requires immediate medical attention and prompt treatment. In the United States, cases of N. meningitidis serogroup Y increased sharply in 2023, leading to a CDC health advisory issued in March 2024, alerting public health agencies and healthcare providers of this surge. N. meningitidis serogroup Y is of particular concern because these strains demons…

  • Direct detection of drug-resistant Mycobacterium tuberculosis using targeted next generation sequencing

    Open Access•Shannon G Murphy, Carol Smith et al.•ARTICLE•Frontiers in Public Health•2023

    Mycobacterium tuberculosis complex (MTBC) infections are treated with combinations of antibiotics; however, these regimens are not as efficacious against multidrug and extensively drug resistant MTBC. Phenotypic (growth-based) drug susceptibility testing on slow growing bacteria like MTBC requires many weeks to months to complete, whereas sequencing-based approaches can predict drug resistance (DR) with reduced turnaround time. We sought to devel…

No prominent works on this page.

  • Direct detection of drug-resistant Mycobacterium tuberculosis using targeted next generation sequencing

    Open Access•Shannon G Murphy, Carol Smith et al.•ARTICLE•Frontiers in Public Health•2023

    Mycobacterium tuberculosis complex (MTBC) infections are treated with combinations of antibiotics; however, these regimens are not as efficacious against multidrug and extensively drug resistant MTBC. Phenotypic (growth-based) drug susceptibility testing on slow growing bacteria like MTBC requires many weeks to months to complete, whereas sequencing-based approaches can predict drug resistance (DR) with reduced turnaround time. We sought to devel…

  • Investigation of invasive Neisseria meningitidis serogroup Y ST1466 case increases in New York State

    Open Access•Krithivasan Sankaranarayanan, Andrew Peifer et al.•ARTICLE•Frontiers in Public Health•2026

    Bacterial meningitis and septicemia caused by Neisseria meningitidis is a serious infection that requires immediate medical attention and prompt treatment. In the United States, cases of N. meningitidis serogroup Y increased sharply in 2023, leading to a CDC health advisory issued in March 2024, alerting public health agencies and healthcare providers of this surge. N. meningitidis serogroup Y is of particular concern because these strains demons…

Amplicon (1 work) · Antibiotic resistance (1 work) · Antibiotic Resistance in Bacteria (1 work) · Bacterial Infections and Vaccines (1 work) · Biology (1 work) · Ciprofloxacin (1 work) · Drug resistance (1 work) · Gene (1 work) · Genetics (1 work) · Infective Endocarditis Diagnosis and Management (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae